CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
Aetna, a CVS Health company (NYSE: CVS), released results from its Q2 2026 Aetna Provider Survey, a quarterly study of 723 U.S. providers conducted by Morning Consult. The average provider-payer trust score rose to 6.1 on a 1–10 scale, up from 5.4 in Q1, with 38% rating payers 8 or higher.
According to Aetna, providers report improving views of payers: 52% say payers deliver on promises (+16 percentage points vs Q1), 56% see clear coverage information (+12 points), and 44% say payers help patients navigate care (+6 points). Administrative burden remains the top challenge, with 84% citing managing patient records or prior authorization. Providers identify prior authorization submission (58%), re-entering patient data (42%) and claims submission (41%) as key areas for technology support, with over 30% expecting to save more than an hour daily and 80% expecting to save over 30 minutes.
Interoperability and data integrity are the leading technology challenges for 68% of providers, and 29% view real-time patient data as the most important action payers can take. Nearly half (47%) think such data could save more than 10 minutes per appointment, enabling more informed point-of-care decisions (63%), fewer claim denials/resubmissions (54%) and reduced wait times for treatment approvals (47%). Providers also see value in payer digital tools: 71% agree they help patients understand benefits and care options, 68% say they clarify prior authorization status, and 72% say they improve claims status transparency. Looking ahead five years, 84% of respondents expect technology advances to improve health outcomes and 72% expect both population health and patient experience to improve.
CVS (NYSE: CVS), through CVS Caremark, announced a global settlement with the Federal Trade Commission that resolves all outstanding FTC litigation and investigations involving its pharmacy benefit management and affiliated pharmacy businesses, including rebate, pharmacy network contracting, and vertical integration issues.
According to CVS Caremark, the agreement removes ongoing legal overhang and formalizes a series of changes aimed at affordability and transparency, such as aligning member cost sharing with net drug costs, moving away from rebate guarantees and spread pricing, and expanding detailed reporting on drug prices, rebates, and member payments.
CVS Caremark reported negotiating nearly $80 billion in client and member prescription savings last year, delivering nearly $900 million in point-of-sale rebates to 25 million Americans, and expects clients to drive about $450 million in annual savings over each of the next 10 years through expanded point-of-sale rebate adoption and related innovations.
CVS Health (NYSE: CVS) announced that its board of directors has approved a quarterly cash dividend of $0.665 per share on its common stock. The dividend will be paid on August 3, 2026, to shareholders of record as of July 23, 2026.
CVS Health (NYSE: CVS) will hold its second quarter 2026 earnings conference call with analysts and investors on Wednesday, August 5, 2026, at 8:00 a.m. ET.
An audio webcast will be available live and archived for one year at investors.cvshealth.com.
CVS (CVS), through the CVS Health Foundation, is investing $1 million via its Hometown Fund in 20 Rhode Island nonprofits.
Grants support access to health care, food, stable housing and essential services, and follow more than $2.64 million in 2025 charitable giving and other community investments in Rhode Island.
CVS (NYSE:CVS), through the CVS Health Foundation, is awarding $1 million in Hometown Fund grants to 20 nonprofits in Greater Hartford. Funding targets access to health care, food security, stable housing and essential community services.
In 2025, CVS Health and its foundation contributed $2.61 million in charitable giving across Connecticut.
CVS (NYSE: CVS) announced expanded GLP‑1 support across more than 9,000 CVS Pharmacy locations and MinuteClinic virtual care nationwide. The initiative combines lower-cost access, pharmacist guidance, and over-the-counter products to help patients start and stay on GLP‑1 therapy.
Key elements include CVS participation in the CMS Medicare GLP‑1 Bridge program from July 1, 2026, through December 31, 2027, offering eligible Medicare patients select GLP‑1 medications for $50 monthly copays. For commercially insured patients, out-of-pocket costs can be as low as $25 per month with manufacturer coupons, or $149 per month for certain uninsured patients using manufacturer vouchers.
MinuteClinic is launching a new virtual weight management program with $49 self-pay visits, available in 47 states and Washington, D.C., for adults ages 18‑64. Licensed clinicians can assess metabolic health and, when clinically appropriate, prescribe FDA-approved GLP‑1 medications for weight loss with follow-up support.
AM Best affirmed the FSR of A (Excellent) and Long-Term ICR of “a” (Excellent) for Aetna Life Insurance Company, other Aetna Health & Life Group members, Allina Health and Aetna Insurance Company, and CVS Caremark Indemnity, all with stable outlooks.
Affirmations reflect very strong balance sheet strength at Aetna Health & Life Group, improved 2025 earnings after 2024 underwriting losses, stronger Medicare Advantage Star Ratings, and continued support from parent CVS Health (NYSE: CVS), partly offset by elevated CVS financial leverage and high goodwill and intangibles.
CVS Health (NYSE: CVS) received the 2026 Newsweek AI Impact Award in the AI Health Care category for Best Outcomes – Patient Care. The honor recognizes CVS Health's AI-Driven Prescription Interpretation and Instruction Standardization technology embedded in pharmacy dispensing workflows.
The AI uses trained open-source large language models to interpret complex prescription directions and calculate precise dosage supply, helping reduce manual transcription, speed retail prescription fulfillment, and accelerate specialty pharmacy onboarding while keeping pharmacists in final clinical control.
Aetna, a CVS Health company (NYSE: CVS) introduced Aetna Mental Health On Demand, offering real-time access to licensed clinicians via chat, phone or video for members aged 13 and older. The service uses a single-session intervention model, AI-powered tools, and predictive analytics, and is slated for self-insured customers starting January 1, 2027.
During the initial launch, clinicians responded to members in about 13 seconds, aiming to improve access, support care coordination, and reduce avoidable hospitalizations through proactive outreach.